This serology assay validated the above NPC-specific EBV-markers, expressed as glutathione-S-transferase (GST) fusion proteins, and has been further evaluated in populations with intermediate (Taiwan)23 and low (UK)24 risk of NPC in clinical case-control settings. Here, HPGDS is linked to nasopharyngeal carcinoma.